COVID-19 Clinical Oncology FAQ
We understand that during this time of uncertainty due to the COVID-19 Coronavirus pandemic, the gastrointestinal cancer community has many questions and concerns.
We understand that during this time of uncertainty due to the COVID-19 Coronavirus pandemic, the gastrointestinal cancer community has many questions and concerns.
Bristol Myers Squibb Company today announced that Opdivo (nivolumab) 1 mg/kg plus Yervoy (ipilimumab) 3 mg/kg (injections for intravenous use) was approved by the U.S.
Since 2006, the Mesothelioma Center has raised awareness for asbestos exposure & helped thousands of families find treatment & compensation.
The Chan Zuckerberg Initiative (CZI) announced that the Fibrolamellar Cancer Foundation (FCF) is among a select group of patient-led rare.
Georgetown Lombardi Comprehensive Cancer Center was pleased and humbled by the overwhelming response to their inaugural Edward M. Kovach Cura Personalis Lecture held earlier this summer featuring Dr. John Marshall and America’s own Katie Couric where they discussed the the healing power of communication.
The Cancer Caregiver Action Plan was developed based on conversations with fellow caregivers who asked for a way to ‘pay it forward’ — a way to help other caregivers by providing real world perspective and insight into the caregiver journey.
Gastric (stomach) cancer is a disease in which malignant (cancer) cells form in the lining of the stomach. The stomach is in the upper abdomen and helps digest food.
Catch up on our investigator-initiated clinical trials. Ruesch Center faculty and their NIH collaborators are really making an effort to change the standard of care.
Time Counts is supporting individuals caring for a loved one by asking society to give time to connect with a caregiver.
In this webinar, part five of our Transforming Trial Participation webinar series, we will discuss setting course for Alliance’s new strategic initiative to improve clinical trial participation.